Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
activities of daily living
activities of daily living scale
adverse drug reaction
agitation
akathisia
alpha methyldopa hydrazine
Alzheimer's disease
amiodarone
amphotericin B
anticholinergic drugs
anticonvulsants
anticonvulsants, cognitive function with
anticonvulsants, untoward effects of
antidepressant
anxiolytic agents
asterixis
ataxia
ataxia, cerebellar
ataxia, truncal
ataxic gait
autonomic dysfunction
basal ganglia
basal ganglia, lesion of
benign essential tremor
bethanechol
bradykinesia
brain transplantation
burning paresthesia
buspirone
butyrophenone
calcium antagonist
calcium antagonist, side effects of
CAT scan
CAT scan, abnormal
CAT scan, contrast enhanced
CAT scan, emission
CAT scan, emission, abnormal
central nervous system, infection of
cerebrospinal fluid, MHPG(3-methoxy 4-hydroxyphenyl glycol)
cerebrovascular accident
cerebrovascular accident, acute management of
chemotherapy, CNS treatment and complications with
chlorpromazine
cholinergic drug
chorea
cinnarizine
clozapine
cognition
complications
contrast agents, neurotoxicity of
creatine phosphokinase(CPK)elevated
cyanide poison
dementia
depression
diltiazem
diplopia
diquat
disulfiram
dopamine antagonist
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug interactions
drug overdose
dyskinesia
dyskinesia, buccal lingual facial
dystonia
dystonia, drug induced
dystonic reaction, acute
ecstasy
emergencies, neurologic
emergency room
encephalopathy
enzyme inhibition
epidemiology of neurology
facial movement disorder
falling
fetal tissue
fever
flunarizine
fluorouracil
fluoxetine
fluvoxamine
GM1 ganglioside
haloperidol
headache
headache, treatment of
hemiballismus
hemichorea
herbicide
hexane
HMGcoA reductase inhibitors
huffing
human immunodeficiency virus type 1
Huntington's chorea
hyperthermia
iatrogenic neurologic disorders
inclusion bodies, eosinophilic cytoplasmic
intellectual deficit
L-dopa
L-dopa, potentiators of
lenticular nucleus, lesion of
lenticular nucleus, lesion of, bilateral
Lewy body
Lewy body disease, diffuse
lipid lowering agent
lithium
locus ceruleus, lesion of
lovastatin
manganese intoxication
medical-legal aspects of neurology
memory, impairment of
mental status, abnormal
meperidine
metoclopramide
migraine, prophylaxis
migraine, treatment of
misdiagnosis
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MPTP
MRI
MRI, abnormal
multiple system atrophy
myoclonus
naproxen
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neuropathology
neuropathology, brain
neuroprotective agents
neurotoxic
neurotoxin
nonsteroidal anti-inflammatory drug
nursing home
nystagmus
occupational neurologic disorders
octreotide
olanzapine
old age, neurology of
ophthalmoplegia
paresthesias
paresthesias, facial
Parkinson disease
Parkinson disease, arteriosclerotic
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, drug induced
Parkinson disease, exacerbation
Parkinson disease, misdiagnosis
Parkinson disease, progression
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinson disease, unmasked
Parkinsonism hyperpyrexia syndrome
Parkinsonism multiple-system atrophy
Parkinsonism syndrome
paroxetine
paroxysmal nonkinesigenic dyskinesia
phenothiazine
poison, neurologic problems with
prognosis
progressive supranuclear palsy
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
putamen, lesion of
putamen, lesion of, bilateral
quetiapine
Rabbit syndrome
renal failure
review article
rhabdomyolysis
rigidity
risperidone
seizure
seizure, treatment of
selective serotonin reuptake inhibitors
serotonin syndrome
sertraline
sinemet
single photon emission computed tomography
sodium valproate
sodium valproate, toxicity
solvent
stridor
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
substantia nigra tissue
tardive dyskinesia
tardive dyskinesia, treatment of
tardive dystonia
tetrabenazine
tic
toxins, nervous system
transient neurologic deficit
treatment of neurologic disorder
tremor
tremor, jaw
tricyclic antidepressant
vasospasm, cerebral
verapamil
vision, blurred
wheelchair
Showing articles 1000 to 1050 of 1606 << Previous Next >>

GM1 Gangliosidosis in Adults:Clinical and Molecular Analysis of 16 Japanese Patients
Ann Neurol 31:328-332, Yoshida,K.,et al, 1992

Idiopathic Hemiparetic Parkinsonism, A Syndrome Distinct from Idiopathic Parkinsonism
Lancet 339:149-150, DeKeyser,J.,et al, 1992

Selegiline as Initial Treatment of De Novo Parkinsonian Patients
Neurol 42:339-343, Myllyla,V.V.,et al, 1992

Deprenyl Effects of Levodopa Pharmacodynamics, Mood, and Free Radical Scavenging
Neurol 42:541-544, Baronti,F.,et al, 1992

Striatal D2 Receptor Status in Patients with Parkinson's Disease, Striatonigral Degeneration, and PSP, (PET)
Ann Neurol 31:184-192, Brooks,D.J.,et al, 1992

Transplantation of Fetal Dopamine Neurons in Parkinson's Disease:One-year Clin Obser in 2 Pts with Putaminal Implants
Ann Neurol 31:155-165, Lindvall,O.,et al, 1992

Transplantation of Fetal Dopamine Neurons in Parkinson's Disease:PET Studies in 2 Pts with Putaminal Implants
Ann Neurol 31:166-173, Sawle,G.V.,et al, 1992

United Parkinson Foundation Neurotransplantation Registry on Adrenal Medullary Transplants:Presurg, & 1-and 2-yr Follow-up
Neurol 41:1719-1722, Goetz,C.G.,et al, 1991

Challenge Tests to Predict the Dopaminergic Response in Untreated Parkinson's Disease
Neurol 41:1723-1725, Highes,A.J.,et al, 1991

The Apomorphine Test in Parkinsonian Syndromes
JNNP 54:870-872, D'Costa,D.F.,et al, 1991

A Multi-Center, Double-Blind Study on Slow-Release Bromocriptine in the Treatment of Parkinson's Disease
Neurol 41:1598-1602, Mannen,T.,et al, 1991

Pleuropulmonary Disease Associated with Dopamine Agonist Therapy
Ann Neurol 30:613-616, Bhatt,M.H.,et al, 1991

Parkinsonism and Defects of Praxis Following Methanol Poisoning
JNNP 54:843-844, Mozaz,M.J.,et al, 1991

Brain Tumors
NEJM 324:1471-1476, 1555-15641991., Black,P.McL., 1991

Effects of Head Trauma from Motor Vehicle Accidents on Parkinson's Disease
Ann Neurol 29:191-193, Goetz,C.G.&Stebbins,G.T., 1991

Severe Adverse Interaction Between Pethidine and Selegiline
Lancet 337:246, Zornberg,G.L.,et al, 1991

Intranasal Apomorphine in Parkinson's Disease
Neurol 41:761-762, Kleedorfer,B.,et al, 1991

The Epidemiology of Parkinson's Disease, A Case-Control Study of Young-Onset and Old-Onset Patients
Arch Neurol 48:903-907, Stern,M.,et al, 1991

DATATOP and Clinical Neuromythology IX
Special Correspondence, Neurol 41:771-7771991., , 1991

Implantation of Human Fetal Ventral Mesencephalon to the Right Caudate Nucleus in Advanced Parkinson's Disease
Arch Neurol 48:822-827, Henderson,B.T.H.,et al, 1991

Stereotaxic Implantation of Autologous Adrenal Medulla Into Caudate Nucleus in Parkinsonism, One-Year Follow-up
Arch Neurol 48:813-820, Fazzini,E.,et al, 1991

Standard & Controlled-Release Levodopa/Carbidopa in Fluctuating Parkinson's Disease on a Protein Redistribution Diet
Arch Neurol 48:402-405, Karstaedt,P.J.,et al, 1991

Driving in Parkinson's Disease
Neurol 41:517-520, Dubinsky,R.M.,et al, 1991

The Phenotype of the X-Linked Dystonia-Parkinsonism Syndrome, An Assessment of 42 Cases in the Philippines
Medicine 70:179-187, Lee,J.V.,et al, 1991

Preclinical Detection of Parkinson's Disease
Neurology Suppl 2, 41:5-921991., Koller,W.C.&Langston,J.W., 1991

Occurrence of Resting Tremor in Parkinson's Disease
Neurol 41:1298-1299, Rajput,A.H.,et al, 1991

N-Methyl-D-Aspartate Antagonists in the Treatment of Parkinson's Disease
Arch Neurol 48:977-981, Greenamyre,J.T.&O'Brien,C.F., 1991

Mitochondrial Oxidative Phosphorylation Defects in Parkinson's Disease
Ann Neurol 30:332-339, 3301991., Shoffner,J.M.,et al, 1991

Neuroleptic Malignant Synd in Parkinson's after Withdrawal or Alteration of Dopaminergic Therapy
Arch Int Med 151:794-796, Keyser,D.L.&Rodnitzky,R.L., 1991

Controlled-Release Delivery of L-Dopa Associated with Nonfatal Hyperthermia, Rigidity, and Autonomic Dysfunction
Neurol 41:942-943, Cunningham,M.A.,et al, 1991

Audiogenic Epilepsy Induced by a Specific Television Performer
NEJM 325:134-135, Ramani,V., 1991

Autonomic Nervous Function in Progressive Supranuclear Palsy
Arch Neurol 48:1083-1084, vanDijk,J.G.,et al, 1991

Essential Tremor:Clinical Correlates in 350 Patients
Neurol 41:234-238, Lou,J.&Jankovic,J., 1991

Long-Term Suppression of Tremor by Chronic Stimulation of the Ventral Intermediate Thalamic Nucleus
Lancet 337:403-406, Benabid,A.L.,et al, 1991

Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991

Dopa-Responsive Dystonia:Long-Term Treatment Response and Prognosis
Neurol 41:174-181, Nygaard,T.G.,et al, 1991

Environmental Risk Factors in Siblings with Parkinson's Disease
Arch Neurol 48:287-289, Wong,G.F.,et al, 1991

Early Combination of Selegiline and Low-Dose Levodopa as Initial Symptomatic Therapy in Parkinson's Dis
Arch Neurol 48:31-34, Elizan,T.S.,et al, 1991

Young-Onset Parkinson's Disease:A Clinical Review
Neurol 41:168-173, Golbe,L.I., 1991

Early Development of Levodopa-Induced Dyskinesias and Response Fluctuations in Young-Onset Parkinson's Disease
Neurol 41:202-205, Kostic,V., 1991

Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991

Clinicopath Conf
Cerebral Amyloid Angiopathy, Case 27-1991, NEJM 325:42-54991., , 1991

Idazoxan Treatment in Progressive Supranuclear Palsy
Neurol 41:986-991, Ghika,J.,et al, 1991

Positron Emission Tomography in Progressive Supranuclear Palsy
Arch Neurol 48:389-391, Bhatt,M.H.,et al, 1991

Presynaptic Parkinsonism in Olivopontocerebellar Atrophy:Clinical, pathological, and Neurochemical Evidence
Ann Neurol 30:425-428, Pascual,J.,et al, 1991

Neurological and Neuropsychiatric Spectrum of Wilson's Disease:A Prospective Study of 45 Cases
J Neurol 238:281-287, Oder,W.,et al, 1991

Wilson's Disease
In Oxford Textbook of Clin Hepatology, Oxford Univ Press, Vol 2, Ch 20. 1, p. 947, Sternlieb,I.&Scheinberg,I.H., 1991

Stereotactic Ventrolateralis Thalamotomy for Refractory Tremor in Post-Levodopa Era Parkinson's Dis
J Neurosurg 75:723-730, Fox,M.W.,et al, 1991

Treatment of Parkinson's Disease with Electroconvulsive Therapy
Psychiatr Clin North Am 14:925-933, Rasmussen,K.&Abrams,R., 1991

Clozapine is Beneficial for Psychosis in Parkinson's Disease
NEurol 41:1699-1700, Kahn,N.,et al, 1991



Showing articles 1000 to 1050 of 1606 << Previous Next >>